ISL
Ingalls & Snyder LLC’s Corcept Therapeutics CORT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $567M | Sell |
7,722,922
-19,662
| -0.3% | -$1.44M | 20.11% | 1 |
|
2025
Q1 | $884M | Sell |
7,742,584
-357,163
| -4% | -$40.8M | 29.09% | 1 |
|
2024
Q4 | $408M | Sell |
8,099,747
-167,009
| -2% | -$8.42M | 16.01% | 1 |
|
2024
Q3 | $383M | Buy |
8,266,756
+28,650
| +0.3% | +$1.33M | 14.93% | 1 |
|
2024
Q2 | $268M | Sell |
8,238,106
-65,041
| -0.8% | -$2.11M | 11.51% | 1 |
|
2024
Q1 | $209M | Sell |
8,303,147
-48,680
| -0.6% | -$1.23M | 9.24% | 1 |
|
2023
Q4 | $271M | Buy |
8,351,827
+11,634
| +0.1% | +$378K | 12.26% | 1 |
|
2023
Q3 | $227M | Sell |
8,340,193
-20,292
| -0.2% | -$553K | 10.94% | 1 |
|
2023
Q2 | $186M | Sell |
8,360,485
-9,532
| -0.1% | -$212K | 8.91% | 1 |
|
2023
Q1 | $181M | Buy |
8,370,017
+1,544,755
| +23% | +$33.5M | 9.31% | 1 |
|
2022
Q4 | $139M | Sell |
6,825,262
-125,815
| -2% | -$2.56M | 7.54% | 1 |
|
2022
Q3 | $178M | Sell |
6,951,077
-41,171
| -0.6% | -$1.06M | 9.95% | 1 |
|
2022
Q2 | $166M | Buy |
6,992,248
+80,872
| +1% | +$1.92M | 8.69% | 1 |
|
2022
Q1 | $156M | Buy |
6,911,376
+173,478
| +3% | +$3.91M | 6.95% | 1 |
|
2021
Q4 | $133M | Sell |
6,737,898
-315,472
| -4% | -$6.25M | 6.02% | 1 |
|
2021
Q3 | $139M | Sell |
7,053,370
-17,785
| -0.3% | -$350K | 6.36% | 1 |
|
2021
Q2 | $156M | Buy |
7,071,155
+124,423
| +2% | +$2.74M | 6.91% | 1 |
|
2021
Q1 | $165M | Sell |
6,946,732
-355,586
| -5% | -$8.46M | 7.72% | 1 |
|
2020
Q4 | $191M | Sell |
7,302,318
-189,435
| -3% | -$4.96M | 9.43% | 1 |
|
2020
Q3 | $130M | Sell |
7,491,753
-107,536
| -1% | -$1.87M | 8.95% | 1 |
|
2020
Q2 | $128M | Sell |
7,599,289
-404,434
| -5% | -$6.8M | 7.34% | 1 |
|
2020
Q1 | $95.2M | Sell |
8,003,723
-10,628
| -0.1% | -$126K | 6.41% | 1 |
|
2019
Q4 | $97M | Sell |
8,014,351
-697,825
| -8% | -$8.44M | 5.25% | 2 |
|
2019
Q3 | $123M | Buy |
8,712,176
+190,377
| +2% | +$2.69M | 6.01% | 1 |
|
2019
Q2 | $95M | Buy |
8,521,799
+149,798
| +2% | +$1.67M | 4.57% | 2 |
|
2019
Q1 | $98.3M | Sell |
8,372,001
-1,888
| -0% | -$22.2K | 4.68% | 2 |
|
2018
Q4 | $112M | Sell |
8,373,889
-24,371
| -0.3% | -$326K | 5.91% | 2 |
|
2018
Q3 | $118M | Buy |
8,398,260
+1,081,270
| +15% | +$15.2M | 4.96% | 3 |
|
2018
Q2 | $115M | Buy |
7,316,990
+499,450
| +7% | +$7.85M | 5.34% | 2 |
|
2018
Q1 | $112M | Sell |
6,817,540
-106,155
| -2% | -$1.75M | 5.47% | 2 |
|
2017
Q4 | $125M | Buy |
6,923,695
+44,597
| +0.6% | +$805K | 5.75% | 2 |
|
2017
Q3 | $133M | Sell |
6,879,098
-433,537
| -6% | -$8.37M | 6.92% | 2 |
|
2017
Q2 | $86.3M | Sell |
7,312,635
-530,200
| -7% | -$6.26M | 4.68% | 3 |
|
2017
Q1 | $86M | Sell |
7,842,835
-316,844
| -4% | -$3.47M | 4.59% | 2 |
|
2016
Q4 | $59.2M | Sell |
8,159,679
-449,750
| -5% | -$3.27M | 3.23% | 4 |
|
2016
Q3 | $56M | Sell |
8,609,429
-558,811
| -6% | -$3.63M | 3.12% | 5 |
|
2016
Q2 | $50.1M | Buy |
9,168,240
+89,716
| +1% | +$490K | 2.95% | 3 |
|
2016
Q1 | $42.5M | Buy |
9,078,524
+63,405
| +0.7% | +$297K | 2.7% | 4 |
|
2015
Q4 | $44.9M | Buy |
9,015,119
+338,946
| +4% | +$1.69M | 2.87% | 5 |
|
2015
Q3 | $32.6M | Buy |
8,676,173
+469,190
| +6% | +$1.76M | 2.13% | 6 |
|
2015
Q2 | $49.3M | Buy |
8,206,983
+274,905
| +3% | +$1.65M | 2.72% | 5 |
|
2015
Q1 | $44.4M | Buy |
7,932,078
+745,716
| +10% | +$4.18M | 2.45% | 5 |
|
2014
Q4 | $21.6M | Buy |
7,186,362
+73,604
| +1% | +$221K | 1.25% | 17 |
|
2014
Q3 | $19.1M | Buy |
7,112,758
+457,685
| +7% | +$1.23M | 1.03% | 27 |
|
2014
Q2 | $18.6M | Buy |
6,655,073
+155,620
| +2% | +$436K | 0.92% | 28 |
|
2014
Q1 | $28.3M | Buy |
6,499,453
+999,816
| +18% | +$4.36M | 1.52% | 15 |
|
2013
Q4 | $17.7M | Buy |
5,499,637
+219,971
| +4% | +$706K | 0.97% | 27 |
|
2013
Q3 | $8.39M | Buy |
5,279,666
+35,118
| +0.7% | +$55.8K | 0.5% | 47 |
|
2013
Q2 | $9.07M | Buy |
+5,244,548
| New | +$9.07M | 0.58% | 43 |
|